Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Workhorse Stock Already Reflects All the Potential Good News

By Mark R. Hake, CFA

WKHS stock, trading at over 18 times its expected 2021 sales, is overvalued.

Investors Should Cool Their Heels Until the SNOW IPO Pullback

By Mark R. Hake, CFA

Snowflake stock is too expensive right now for most investors. Wait for an opportunity to buy in at a lower price when insider lock-ups expire in early December.

Patient Investors Will Stick With Very Cheap Bristol-Myers Squibb Stock

By Mark R. Hake, CFA

Stick with Bristol-Myers Squibb stock which is incredibly cheap. BMY stock is worth at least 46% more than today, based on its historical yield, P/E ratios, and peer comparisons.

Microsoft’s Cash Flow and Dividends Will Push Its Stock Higher

By Mark R. Hake, CFA

Microsoft's fast-growing cash flow and dividends will push shares higher. MSFT stock is worth $309 per share, or about 49% higher than today.

Stay Away From Hertz Stock Since It Is Very Likely Worthless

By Mark R. Hake, CFA

Stay away from Hertz stock since it is very likely worthless. HTZ stock will not survive the outcome of its Chapter 11 bankruptcy as creditors are still fighting among themselves.

Nvidia’s Using Nosebleed-Valued Stock to Pay for SoftBank’s Chip Unit

By Mark R. Hake, CFA

Avoid NVDA stock which still trades at nosebleed valuation levels. Nvidia has been able to use its high-priced stock for up to 70% of the purchase price of Softbank's ARM chip unit.

This Bud’s Not for You While Debt Swallows Free Cash Flow

By Mark R. Hake, CFA

This Bud's not for you. BUD stock will likely tread water a while until higher free cash flow reduces the debt pile after its recent spike.

Undervalued Wells Fargo Stock Has a Big Comeback Brewing

By Mark R. Hake, CFA

Wells Fargo stock looks like a bargain here selling below tangible book value. Wells Fargo stock is worth at least 44% more than today, given its discount to tangible book value and other value metrics.

Honeywell Stock is Nothing Exciting, so Look Elsewhere for Your Tech Fix

By Mark R. Hake, CFA

Although Honeywell is a solid FCF producer, HON stock trades at a 16% to 20% premium to MMM stock with similar revenue.

Amazon Still Looks Undervalued Thanks to Cash Flow

By Mark R. Hake, CFA

Amazon stock still looks undervalued here. AMZN stock is worth at least 25% more than today, given the power of its huge free cash flow.

Load More